New Deal
Announced
Completed
Share
Financials
Show More
Relypsa
Galenica
Sources
Tags
treatment development
biotechnology
pharmaceuticals
Pharmaceuticals
United States
Public
Acquisition
Friendly
Synopsis
Sale of Relypsa, a biopharmaceutical developer of non-absorbed polymeric drugs for treatment of cardiovascular and renal diseases, to Galenica.
Service Providers (5)
Dealmakers
Centerview Partners
Bank Of America
Latham & Watkins
Credit Suisse
Jones Day
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.